(Reuters) – The European medicines regulator said on Monday it was evaluating an application to use immunosuppressant drug Kineret to treat COVID-19 in adult patients with pneumonia who are at risk of developing severe respiratory failure.
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Shailesh Kuber)
